Cargando…

Rivaroxaban – a safe therapeutic option in patients with antiphospholipid syndrome? Our experience in 23 cases

In the therapeutic approach to patients with antiphospholipid syndrome (APS) with thrombotic manifestations, oral vitamin K antagonists (VKA) remain the standard of care. However, the use of VKA is very often associated with inability to achieve a therapeutic dose even in patients maintaining nutrit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haładyj, Ewa, Olesińska, Marzena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2016
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967983/ https://www.ncbi.nlm.nih.gov/pubmed/27504026 http://dx.doi.org/10.5114/reum.2016.61217

Ejemplares similares

Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome
por: Haładyj, Ewa, et al.
Publicado: (2016)

Antimalarials – are they effective and safe in rheumatic diseases?
por: Haładyj, Ewa, et al.
Publicado: (2018)

Treatment of rheumatic diseases and hepatitis B virus coinfection
por: Felis-Giemza, Anna, et al.
Publicado: (2014)

Relationship between type of skin lesions and nailfold capillaroscopy pattern in mixed connective tissue disease
por: Felis-Giemza, Anna, et al.
Publicado: (2021)

A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome
por: Legault, Kimberly, et al.
Publicado: (2020)

Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE
por: Cohen, H, et al.
Publicado: (2015)

Improvement of Cardiac Vegetations in Antiphospholipid Syndrome with Enoxaparin and Corticosteroids after Rivaroxaban Failure
por: Granowicz, Eric, et al.
Publicado: (2018)

Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome
por: Legault, Kimberly, et al.
Publicado: (2020)

Rivaroxaban and early periprostethic joint infection: our experience
por: Di Benedetto, Paolo, et al.
Publicado: (2017)

RORC2 Genetic Variants and Serum Levels in Patients with Rheumatoid Arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2016)

Neurological manifestations in patients with antiphospholipid syndrome
por: Etemadifar, Masoud, et al.
Publicado: (2013)

Relationship between VEGF Gene Polymorphisms and Serum VEGF Protein Levels in Patients with Rheumatoid Arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2016)

FLT-1 gene polymorphisms and protein expression profile in rheumatoid arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2017)

Development of intracardiac thrombus in a young patient with antiphospholipid syndrome while she was on rivaroxaban: Case report and literature review
por: Abdelmahmuod, Elabbass A., et al.
Publicado: (2021)

SUN-192 Spontaneous Adrenal Hemorrhage in a Patient with Antiphospholipid Syndrome on Rivaroxaban: A Potentially Fatal Complication
por: DiCenso, Daniela Maria, et al.
Publicado: (2020)

Immunopathogenesis and Novel Therapeutics Strategies of Systemic Lupus Erythematosus
por: Kotyla, Przemysław, et al.
Publicado: (2023)

Point of care testing to monitor INR control in patients with antiphospholipid syndrome
por: Masucci, Michael, et al.
Publicado: (2022)

Our initial single port robotic cholecystectomy experience: A feasible and safe option for benign gallbladder diseases
por: Rasa, Huseyin Kemal, et al.
Publicado: (2022)

Primary antiphospholipid syndrome presenting as antiphospholipid syndrome nephropathy: a case report
por: Abeysekera, Rajitha Asanga, et al.
Publicado: (2015)

Subgroups of Sjögren’s syndrome patients categorised by serological profiles: clinical and immunological characteristics
por: Kontny, Ewa, et al.
Publicado: (2018)

Therapeutic Challenges with Catastrophic Antiphospholipid Antibody Syndrome: A Case Report
por: Harne, Prateek, et al.
Publicado: (2020)

IL-35, TNF-α, BAFF, and VEGF serum levels in patients with different rheumatic diseases
por: Wojdasiewicz, Piotr, et al.
Publicado: (2019)

Antiphospholipid antibodies and thrombosis: pathogenesis of antiphospholipid syndrome
por: Koike, T
Publicado: (2003)

Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
por: Devreese, Katrien M.J., et al.
Publicado: (2021)

Case-based Learning: Our Experience in Clinical Pharmacology Teaching
por: Hasamnis, Ameya A., et al.
Publicado: (2019)

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications
por: Tedesco, Francesco, et al.
Publicado: (2018)

Natural compounds as safe therapeutic options for ulcerative colitis
por: Gupta, Mukta, et al.
Publicado: (2022)

Is It Antiphospholipid Syndrome?
por: Ditto, Maria Chiara, et al.
Publicado: (2010)

Antiphospholipid syndrome
por: Espinosa, Gerard, et al.
Publicado: (2008)

The Antiphospholipid Syndrome
por: Hughes, Graham R V, et al.
Publicado: (1994)

Antiphospholipid antibodies in black south africans with hiv and acute coronary syndromes: prevalence and clinical correlates
por: Becker, Anthony C, et al.
Publicado: (2011)

The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome
por: Youkhana, Kimberley, et al.
Publicado: (2023)

Myopia: Risk Factors, Disease Mechanisms, Diagnostic Modalities, and Therapeutic Options
por: Mrugacz, Malgorzata, et al.
Publicado: (2018)

Obstetrical Antiphospholipid Syndrome: From the Pathogenesis to the Clinical and Therapeutic Implications
por: Marchetti, T., et al.
Publicado: (2013)

Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics
por: Yadav, Manoj Kumar, et al.
Publicado: (2022)

Artherial thrombosis with antiphospholipid syndrome in 17 year old female patient: case of familial antiphospholipid syndrome
por: Vidović, M, et al.
Publicado: (2011)

Antiphospholipid Syndrome and Antibodies
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2014)

Management of the antiphospholipid syndrome
por: Espinosa, Gerard, et al.
Publicado: (2010)

Treatment of the antiphospholipid syndrome
por: Galli, Monica
Publicado: (2013)

Pathogenesis of Antiphospholipid Syndrome
por: Bo•ic, Borut
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_gp7ap6jecuhua53i129s808rl3